LILLY FDA Approval ANDA 086530

ANDA 086530

LILLY

FDA Drug Application

Application #086530

Application Sponsors

ANDA 086530LILLY

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004

Application Products

001SUPPOSITORY;RECTAL30MG0SECONAL SODIUMSECOBARBITAL SODIUM
002SUPPOSITORY;RECTAL60MG0SECONAL SODIUMSECOBARBITAL SODIUM
003SUPPOSITORY;RECTAL120MG0SECONAL SODIUMSECOBARBITAL SODIUM
004SUPPOSITORY;RECTAL200MG0SECONAL SODIUMSECOBARBITAL SODIUM

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 86530
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.